# Ingersoll Rand Inc. (IR)

> Source: Nexqual · https://nexqual.com/IR · data as of 2026-10-23 16:22 UTC · cite as "Nexqual, Ingersoll Rand Inc. (IR), nexqual.com/IR" · informational, not investment advice.

**Price:** USD 73.75 (-0.49% today) · US market open, as of October 23, 2026 at 16:22 UTC; quotes may be delayed. Prev close 74.11 · day 72.36–74.14 · 52w 68.07–100.96 · market cap $28.6B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $7.94B, net income $959M (12.1% margin), free cash flow $1.22B (SEC filings).
- Valuation: P/E 29.8x (avg 46.4x at the last 3 fiscal year-ends), EV/EBITDA 16.3x, net debt $3.60B.
- 2 of 80 tracked superinvestors hold IR (13F, Q2 2026): 0 new, 2 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $2.7M; 0 not under a Rule 10b5-1 plan ($0K); 1 by opportunistic insiders (0 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $1.0M; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.50 on a 1–5 scale) (14 analysts), mean target USD 94.1 (range 82–109).
- Total return with dividends: 1Y -8.1% vs S&P 500 +14.7%; 5Y +38.0% vs S&P 500 +77.5%.
- Next earnings: 2026-10-29, EPS estimate USD 0.9, revenue estimate $2.05B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.15B | $5.92B | $6.88B | $7.24B | $7.65B | $7.94B |
| Gross profit | $1.99B | $2.33B | $2.88B | $3.17B | $3.34B | — |
| Operating income | $566M | $817M | $1.16B | $1.30B | $1.14B | $1.44B |
| Net income | $563M | $605M | $779M | $839M | $581M | $959M |
| EPS (diluted) | $1.34 | $1.47 | $1.90 | $2.06 | $1.45 | — |
| Free cash flow | $564M | $771M | $1.27B | $1.25B | $1.22B | $1.22B |
| Gross margin | 38.6% | 39.3% | 41.9% | 43.8% | 43.6% | — |
| Operating margin | 11.0% | 13.8% | 16.9% | 18.0% | 15.0% | 18.1% |
| Net margin | 10.9% | 10.2% | 11.3% | 11.6% | 7.6% | 12.1% |
| Revenue growth | +29.7% | +14.8% | +16.2% | +5.2% | +5.7% | — |
| Cash + short-term investments | $2.11B | $1.61B | $1.60B | $1.54B | $1.25B | — |
| Total debt | $2.82B | $2.75B | $2.72B | $4.76B | $4.78B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 29.8x · P/S 3.6x · EV/EBITDA 16.3x · EV/Sales 4.1x · P/FCF 23.5x · P/B 2.8x · FCF yield 4.26% · Earnings yield 3.35% · Dividend yield (paid, TTM) 0.11% · Buyback yield (TTM) 2.96% · Net debt $3.60B · EV $32.2B
P/E at fiscal year-ends: Dec 2025 54.6x, Dec 2024 43.9x, Dec 2023 40.6x.

## Superinvestors (SEC 13F-HR, Q2 2026)
2 of 80 tracked investors hold IR. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Sarah Ketterer | Causeway Capital Management | 0.92% | $84.8M | Added +65.1% |
| Wallace Weitz | Weitz Investment Management | 0.92% | $13.3M | Added +21.4% |

## Insider sales (SEC Form 4, open-market, last ~7 months)
1 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-04-13 | Reynal Vicente | See Remarks | 30,492 | $2.7M | 7.9% | Yes (adopted May 22, 2025) | Opportunistic (traded every year 2023–2025, no repeating month) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Insider purchases (SEC Form 4, open-market, last ~7 months)
1 purchase, $1.0M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-03 | Satpathy Aurobind | Director | 11,538 | $1.0M | 86.68 | Too little history (no open-market trades in 2023–2025) |

## Analysts
Consensus Hold (mean 2.50 on a 1–5 scale), 14 analysts; mean target USD 94.1 (low 82, high 109).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | Evercore ISI Group | Target raised | In-Line | $84 → $93 |
| 2026-08-03 | Baird | Target raised | Outperform | $103 → $109 |
| 2026-07-20 | Stifel | Target lowered | Hold | $85 → $84 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -8.1% | +38.0% |
| S&P 500 (SPY) | +14.7% | +77.5% |
| Per year | -8.2% | +6.7% |
| Volatility (annualized) | 32.9% | 30.0% |
| Max drawdown | -30.6% (Feb 2026→May 2026) | -33.7% (Dec 2021→Jul 2022) |

## Peers (Specialty Industrial Machinery)
OTIS (Otis Worldwide Corporation) USD 75.06 -0.71% · DOV (Dover Corporation) USD 196.93 +0.74% · XYL (Xylem Inc.) USD 109.2 -0.05% · NDSN (Nordson Corporation) USD 319.41 +0.22% · ROK (Rockwell Automation, Inc.) USD 428.26 +1.03% · ITT (ITT Inc.) USD 189.77 +0.80%

## More
Full page: https://nexqual.com/IR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in IR's own 10-K filed 2026-02-17 (https://www.sec.gov/Archives/edgar/data/1699150/000162828026008617/iri-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Competitor | Thermo Fisher (TMO) | "Our primary competitors include Dover, Graco, IDEX Corporation, KNF Neuberger, Netzsch, NOV, Sartorius, SPX Flow, Thermo Fisher Scientific, and Watson-Marlow, as well as other regional and local manufacturers." |

## Revenue by business segment (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Industrial Technologies and Services | $1.62B | 79.2% | +8.7% |
| Precision and Science Technologies | $426.7M | 20.8% | +7.7% |
| Total revenue | $2.05B | 100% | — |

## Revenue by product line (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Original equipment | $975.2M | 47.6% | +10.2% |
| Aftermarket | $646.9M | 31.6% | +6.6% |
| Total revenue | $2.05B | 100% | — |
The lines above cover 79.2% of total revenue.

## Revenue by region (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Americas | $979.7M | 47.8% | +2.6% |
| — U.S. Plans (part of Americas) | $809.5M | 39.5% | +1.4% |
| — Other Americas (part of Americas) | $170.2M | 8.3% | +8.7% |
| EMEIA | $674.3M | 32.9% | +10.4% |
| Total Asia Pacific | $394.8M | 19.3% | +22.6% |
| — China (part of Total Asia Pacific) | $248.0M | 12.1% | +18.9% |
| — Other Asia Pacific (part of Total Asia Pacific) | $146.8M | 7.2% | +29.5% |
| Total revenue | $2.05B | 100% | — |

## Company outlook (8-K filed 2026-07-30)

- "Guidance 4,5,6,7 Ingersoll Rand is updating its full-year 2026 guidance."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.90 | $0.91 | -0.6% | $2.05B | 13 |
| Next quarter (ends 2026-12-31) | $1.02 | $1.00 | +1.7% | $2.17B | 12 |
| Current fiscal year (ends 2026-12-31) | $3.55 | $3.50 | +1.4% | $8.12B | 14 |
| Next fiscal year (ends 2027-12-31) | $3.91 | $3.85 | +1.5% | $8.52B | 14 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-10-29): ±10.5%; last 8 reports averaged ±4.9%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 46.7% | ±10.5% |
| 2026-12-18 | 56 | 35.6% | ±11.3% |
| 2027-01-15 | 84 | 34.0% | ±13.1% |
| 2027-03-19 | 147 | 35.1% | ±17.9% |
| 2027-06-17 | 237 | 36.4% | ±23.4% |
| 2027-09-17 | 329 | 35.8% | ±26.9% |